Background The purpose of this study was to establish a nomogram combining classical
parameters and immunohistochemical markers to predict the recurrence of patients with …

Objective The aim of this study was to establish a nomogram to predict the recurrence of
endometrial cancer (EC) by immunohistochemical markers and clinicopathological …

Background The purpose of this study was to construct a nomogram based on classical
parameters and immunohistochemical markers to predict the recurrence of early low-risk …

Recurrence is the main cause of death in patients with endometrial cancer (EC). This study
aimed to construct and validate a nomogram to predict the recurrence-free survival of …

Objective The study aimed to develop a prediction model combining clinical and histological
features to predict recurrence in patients with stage I-II endometrial cancer (EC) after …

OBJECTIVE: Type II endometrial cancer (EC) is associated with high risk of metastasis and
poor prognosis. We aimed to develop a nomogram for predicting survival probability in …

Objective Traditionally, the prognosis of patients with FIGO stage I endometrial cancer is
determined by clinicopathological risk factors. In this study, we assessed the potential …

Objective To develop and validate a 3-year recurrence prediction score (RPS) system for
predicting the baseline risk of recurrence of stage I–II endometrial carcinoma. Methods We …

Objective Existing prognostic models for endometrial cancer are short of facility and effective
validation. In this study, we aim to develop and validate a novel prognostic model for …

Simple Summary Optimum risk stratification in the early stages of endometrial cancer
combines molecular and clinicopathological features. The purpose of the study was to …